Literature DB >> 3989184

Patterns of mental disorders among the elderly residents of eastern Baltimore.

M Kramer, P S German, J C Anthony, M Von Korff, E A Skinner.   

Abstract

An extensive analysis of prevalence rates of cognitive impairment and other mental morbidities was carried out as part of a five-site national study on the health and mental health of an ambulatory population. This study reports on prevalence rates contrasted by age across the 18 and over population for cognitive impairment and other diagnoses in the Baltimore, Maryland, site of this study. Differences in prevalence rates by age are striking. Eight conditions have rates above 1 per cent among those 64 and younger: phobia (13.8 per cent), alcohol use disorder (6.5 per cent), obsessive compulsive disorder (2.2 per cent), schizophrenia (1.4 per cent), and panic disorder (1.2 per cent). For the older group, 65 to 74 years, five conditions have such prevalence rates: phobic disorder (12.1 per cent), severe cognitive impairment (3.0 per cent), alcohol use disorder (2.1 per cent), obsessive compulsive disorder (2.2 per cent), and dysthymia (1.0 per cent). For the oldest group, those 75 and over, only four conditions have rates of 1 per cent or more. These are: phobic disorders (10.1 per cent), severe cognitive impairment (9.3 per cent), major depression (1.3 per cent), and dysthymia (1.1 per cent). Rates of cognitive impairment increase markedly with age and high rates of this disorder were found among those never married, separated, divorced, or widowed. Implications of these findings for understanding mental morbidity among the elderly and issues for future planning are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 3989184     DOI: 10.1111/j.1532-5415.1985.tb07110.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  21 in total

1.  Determinants of psychiatric rehospitalization: a social area analysis.

Authors:  T T Wan; Y A Ozcan
Journal:  Community Ment Health J       Date:  1991-02

2.  Black and white differences in cognitive function test scores: what explains the difference?

Authors:  Kala M Mehta; Eleanor M Simonsick; Ronica Rooks; Anne B Newman; Sandra K Pope; Susan M Rubin; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

Review 3.  The epidemiology of dementia in North America.

Authors:  M R Eastwood; S L Rifat; D Roberts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

4.  Black-white differences in alcohol use by women: Baltimore survey findings.

Authors:  M Lillie-Blanton; E MacKenzie; J C Anthony
Journal:  Public Health Rep       Date:  1991 Mar-Apr       Impact factor: 2.792

Review 5.  Lessons from geriatric psychiatry in the long-term care setting.

Authors:  J E Streim; D Oslin; I R Katz; P A Parmelee
Journal:  Psychiatr Q       Date:  1997

Review 6.  Differential pharmacokinetics of lithium in elderly patients.

Authors:  B A Sproule; B G Hardy; K I Shulman
Journal:  Drugs Aging       Date:  2000-03       Impact factor: 3.923

Review 7.  St John's wort: a potential therapy for elderly depressed patients?

Authors:  E U Vorbach; K H Arnoldt; E Wolpert
Journal:  Drugs Aging       Date:  2000-03       Impact factor: 3.923

Review 8.  The pharmacoeconomics of dementia therapies. Bringing the clinical, research and economic perspectives together.

Authors:  F J Molnar; W B Dalziel
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

9.  A dimensional liability model of age differences in mental disorder prevalence: evidence from a national sample.

Authors:  Nicolas Hoertel; Kibby McMahon; Mark Olfson; Melanie M Wall; Jorge Mario Rodríguez-Fernández; Cédric Lemogne; Frédéric Limosin; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2015-03-28       Impact factor: 4.791

Review 10.  Pharmacologic treatment of geriatric mania.

Authors:  William M McDonald; John Wermager
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.